Optune is an innovative medical device developed by NovoCure for the treatment of glioblastoma, an aggressive form of brain cancer. The device uses Tumor Treating Fields (TTFields), which are low-intensity, alternating electric fields that disrupt cancer cell division. By wearing Optune, patients receive continuous therapy directly to the tumor site, targeting cancer cells while sparing healthy tissue. Clinical studies have shown that when used alongside standard treatments like chemotherapy, Optune can significantly improve progression-free survival and overall survival rates in patients with newly diagnosed or recurrent glioblastoma.

Memorial Radiation Oncology Medical Group can provide a custom plan for your tumor location. Contact us to learn more.